Itamar Medical to Report Second Quarter 2019 Financial Results and Host Conference Call on Wednesday, August 14, 2019

Itamar Medical Ltd. (Nasdaq: ITMR) (TASE: ITMR), a company that develops, manufactures and markets non-invasive diagnostic medical devices for sleep apnea with a focus on the cardiology market, announced today that it will report its unaudited financial results for the second quarter of 2019 before the U.S. market opens on Wednesday, August 14, 2019.